Skip to main content

EDROPHONIUM

Tracking # 20-839115

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

EDROPHONIUM IS A MEDICATION USED IN THE DIAGNOSIS OF MYASTHENIA GRAVIS. IT IS IN THE ACETYLCHOLINESTERASE CLASS OF DRUGS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, CONTRAINDICATIONS FOR EDROPHONIUM AS A VALUABLE AGENT IN THE MANAGEMENT OF MYASTHENIA GRAVIS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE DIAGNOSIS OF PATIENTS WITH MYASTHENIA GRAVIS AND RELATED CONDITIONS.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I